BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36094276)

  • 1. Dickkopf-1 expression is repressed by oncogenic human papillomaviruses (HPVs) and regulates the Cisplatin sensitivity of HPV-positive cancer cells in a JNK-dependent manner.
    Frensemeier K; Holzer A; Hoppe-Seyler K; Hoppe-Seyler F
    Int J Cancer; 2022 Dec; 151(12):2215-2228. PubMed ID: 36094276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.
    Hoppe-Seyler K; Bossler F; Lohrey C; Bulkescher J; Rösl F; Jansen L; Mayer A; Vaupel P; Dürst M; Hoppe-Seyler F
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E990-E998. PubMed ID: 28115701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.
    Putral LN; Bywater MJ; Gu W; Saunders NA; Gabrielli BG; Leggatt GR; McMillan NA
    Mol Pharmacol; 2005 Nov; 68(5):1311-9. PubMed ID: 16120770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the antifungal agent ciclopirox in HPV-positive cancer cells: Repression of viral E6/E7 oncogene expression and induction of senescence and apoptosis.
    Braun JA; Herrmann AL; Blase JI; Frensemeier K; Bulkescher J; Scheffner M; Galy B; Hoppe-Seyler K; Hoppe-Seyler F
    Int J Cancer; 2020 Jan; 146(2):461-474. PubMed ID: 31603527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Metformin on the virus/host cell crosstalk in human papillomavirus-positive cancer cells.
    Hoppe-Seyler K; Herrmann AL; Däschle A; Kuhn BJ; Strobel TD; Lohrey C; Bulkescher J; Krijgsveld J; Hoppe-Seyler F
    Int J Cancer; 2021 Sep; 149(5):1137-1149. PubMed ID: 33844847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis.
    Butz K; Geisen C; Ullmann A; Spitkovsky D; Hoppe-Seyler F
    Int J Cancer; 1996 Nov; 68(4):506-13. PubMed ID: 8945623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
    Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
    J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of Human Papillomavirus Oncogene Expression under Hypoxia Is Mediated by PI3K/mTORC2/AKT Signaling.
    Bossler F; Kuhn BJ; Günther T; Kraemer SJ; Khalkar P; Adrian S; Lohrey C; Holzer A; Shimobayashi M; Dürst M; Mayer A; Rösl F; Grundhoff A; Krijgsveld J; Hoppe-Seyler K; Hoppe-Seyler F
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells.
    Zhang X; Zhang A; Zhang X; Hu S; Bao Z; Zhang Y; Jiang X; He H; Zhang TC
    Virus Res; 2021 Dec; 306():198602. PubMed ID: 34662680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
    Munagala R; Kausar H; Munjal C; Gupta RC
    Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of cycling hypoxia on the phenotype of HPV-positive cervical cancer cells.
    Heber N; Kuhn BJ; Strobel TD; Lohrey C; Krijgsveld J; Hoppe-Seyler K; Hoppe-Seyler F
    J Med Virol; 2023 Dec; 95(12):e29280. PubMed ID: 38054507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.
    Wallace NA; Khanal S; Robinson KL; Wendel SO; Messer JJ; Galloway DA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.
    Jung HS; Erkin OC; Kwon MJ; Kim SH; Jung JI; Oh YK; Her SW; Ju W; Choi YL; Song SY; Kim JK; Kim YD; Shim GY; Shin YK
    Int J Cancer; 2012 Apr; 130(8):1925-36. PubMed ID: 21630254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.